Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $9.45, but opened at $8.8750. Aspen Pharmacare shares last traded at $8.8750, with a volume of 104 shares trading hands.
Aspen Pharmacare Trading Down 2.1%
The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66. The stock has a 50-day simple moving average of $8.90 and a 200-day simple moving average of $8.18.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
- A $1.5 Billion Wake-Up Call for Every AI Company on Wall Street
- AMD’s AI Bubble Could Burst Into Explosive Upside
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
